Predictors of response to terlipressin therapy in hepatorenal syndrome: Metabolomic and proteomic analysis from the CONFIRM trial by Cyrus Huneycutt | Sep 1, 2025 | 0 comments Submit a Comment Cancel replyYou must be logged in to post a comment.
Recent Comments